This is a test: Applied DNA Sciences can now do its own clinical testing, perchance to speed up regulatory approvals of new COVID-19 tests and other potential breakthroughs.
By GREGORY ZELLER //
One of Long Island’s busiest biotechs has spun off another local startup, this time focused on testing its own potential breakthroughs.
Stony Brook-based Applied DNA Sciences, which has quickly evolved from an upstart DNA-based supply-chain authenticator to a leader in unique DNA manufacturing, has launched Applied DNA Clinical Labs LLC, a wholly owned subsidiary dedicated to the commercial development of two key verticals: Applied DNA’s virology tests, designed to quickly detect COVID-19, and its oncology tests, designed to sniff out invading cancer cells.
